Autoinjectors to 2018 Devices, Therapeutics, Markets, Strategies and Prospect


Dublin, Nov. 5, 2013 (GLOBE NEWSWIRE) -- Research and Markets (http://www.researchandmarkets.com/research/vm4pm3/autoinjectors_to) has announced the addition of the "Autoinjectors to 2018 Devices, Therapeutics, Markets, Strategies and Prospect" report to their offering.

While autoinjectors are sometimes designed to work with a particular injectable product as a form of pharmaceutical branding, the typical autoinjector is designed to fit one or more standard sizes of prefilled disposable syringes. Until recently, autoinjectors were designed to be reused. The reason was that the injectors were too expensive to be successfully marketed as a throw-away device. Recent improvements in materials technology and device design have led to the creation of a class of autoinjectors that can be made economically in high production quantities, opening the door for the disposable autoinjector, and providing expanded opportunities for both patient and drug marketer.

Highlights

  • Analyzes therapeutic demand drivers and evaluates commercial prefilled syringe products in eleven major therapeutic segments
  • Analyzes design factors, material selection issues, technologies and market development issues
  • Profiles injectable drug and device participants, their product development activities, business strategies, and corporate alliances and affiliations
  • Charts market data and forecasts to 2018

Key Topics Covered

Executive Summary
Injectable Drug Delivery Market Dynamics
Autoinjectors - Commercial Devices
Autoinjector Device Design Factors
Autoinjector Drug Delivery - Key Therapeutic Sector Analysis
Market Factors
Autoinjector Devices - Company Profiles

For more information visit http://www.researchandmarkets.com/research/vm4pm3/autoinjectors_to

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Drug Delivery